Copyright
©The Author(s) 2022.
World J Gastroenterol. Aug 7, 2022; 28(29): 3767-3779
Published online Aug 7, 2022. doi: 10.3748/wjg.v28.i29.3767
Published online Aug 7, 2022. doi: 10.3748/wjg.v28.i29.3767
Table 1 Systemic mastocytosis criteria according to World Health Organization 2016
| Major SM criterion | Multifocal dense infiltrates of MCs (≥ 15 MCs in aggregates) in BM biopsies and/or in sections of other extracutaneous organ(s) |
| Minor SM criteria | (a) > 25% of all MCs are atypical cells (type I or type II) on BM smears or are spindle-shaped in MC infiltrates detected on sections of visceral organs |
| (b) KIT point mutation at codon 816 in the BM or another extracutaneous organ | |
| (c) MCs in BM or blood or another extracutaneous organ exhibit CD2 and/or CD25 | |
| (d) Baseline serum tryptase level >20 ng/mL (in case of an unrelated myeloid neoplasm, item d is not valid as an SM criterion) |
Table 2 B and C Findings in systemic mastocytosis
| B and C Findings in systemic mastocytosis |
| B Findings |
| BM biopsy showing > 30% infiltration by MCs (focal, dense aggregates) and serum total tryptase level > 200 ng/mL |
| Myeloproliferation or signs of dysplasia in non-MC lineage(s), no prominent cytopenias; criteria for AHN not met |
| Hepatomegaly and/or splenomegaly on palpation without impairment of organ function and/or lymphadenopathy on palpation/imaging (> 2 cm) |
| C Findings1 |
| Cytopenia(s): ANC < 1 × 109/L, Hb < 10 g/dL, or platelets < 100 × 109/L |
| Hepatomegaly on palpation with impairment of liver function, ascites, and/or portal hypertension |
| Skeletal lesions: Osteolyses and/or pathologic fractures |
| Palpable splenomegaly with hypersplenism |
| Malabsorption with weight loss from gastrointestinal tract MC infiltrates |
Table 3 Differential diagnosis between systemic mastocytosis and gastrointestinal diseases
| Symptoms | Differential diagnosis |
| Chronic diarrhea | Irritable bowel syndrome; Inflammatory bowel disease; Celiac disease; Thyreopathies (i.e. hyperthyroidism, medullary thyroid cancer); Pancreatopathyes |
| Epigastric pain, dyspepsia, heartburn | Functional dyspepsia; Peptic ulcer; Gastroesophageal reflux disease; H. pylori related gastritis; Zollinger-Ellison Syndrome |
| Flushing | Neuroendocrine neoplasms |
| Hepato-splenomegaly, portal hypertension | Cirrhosis; Non cirrhotic portal hypertension |
- Citation: Elvevi A, Elli EM, Lucà M, Scaravaglio M, Pagni F, Ceola S, Ratti L, Invernizzi P, Massironi S. Clinical challenge for gastroenterologists–Gastrointestinal manifestations of systemic mastocytosis: A comprehensive review. World J Gastroenterol 2022; 28(29): 3767-3779
- URL: https://www.wjgnet.com/1007-9327/full/v28/i29/3767.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i29.3767
